What is Marker Therapeutics, Inc. Common Stock's Market Cap?

Marker Therapeutics, Inc. Common Stock's Market Cap is $21.3M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Enterprise Value?

Marker Therapeutics, Inc. Common Stock's Enterprise Value is $10.0M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Price / Sales?

Marker Therapeutics, Inc. Common Stock's Price / Sales is 6.0×, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's EV / Revenue?

Marker Therapeutics, Inc. Common Stock's EV / Revenue is 2.8×, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Revenue (TTM)?

Marker Therapeutics, Inc. Common Stock's Revenue (TTM) is $3.5M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Net Income (TTM)?

Marker Therapeutics, Inc. Common Stock's Net Income (TTM) is -$8.7M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Net Debt?

Marker Therapeutics, Inc. Common Stock's Net Debt is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

Marker Therapeutics, Inc. Common Stock (MRKR) Financial Statements

Marker Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SKLLN7

XNAS · usd

1.28▲ 0.10 (8.47%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.18

Day's Range1.19 – 1.39

52-Week Range0.83 – 2.46

Volume200.3K

Avg Volume74.6K

Share Statistics

Shares Outstanding

Employees5

ExchangeXNAS

Listed1998-01-07

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Marker Therapeutics, Inc. Common Stock (MRKR)

What is Marker Therapeutics, Inc. Common Stock's Market Cap?: Marker Therapeutics, Inc. Common Stock's Market Cap is $21.3M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Enterprise Value?: Marker Therapeutics, Inc. Common Stock's Enterprise Value is $10.0M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Price / Sales?: Marker Therapeutics, Inc. Common Stock's Price / Sales is 6.0×, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's EV / Revenue?: Marker Therapeutics, Inc. Common Stock's EV / Revenue is 2.8×, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Revenue (TTM)?: Marker Therapeutics, Inc. Common Stock's Revenue (TTM) is $3.5M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Net Income (TTM)?: Marker Therapeutics, Inc. Common Stock's Net Income (TTM) is -$8.7M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Net Debt?: Marker Therapeutics, Inc. Common Stock's Net Debt is -$11.3M, based on as-reported figures from SEC (XBRL) filings.